Pingping Cai | Medicine | Best Researcher Award

Dr. Pingping Cai | Medicine | Best Researcher Award

Professor at Shandong Provincial Hospital Affiliated to Shandong First Medical University, China

Prof. Pingping Cai is a distinguished expert in Traditional Chinese Medicine (TCM), specializing in gynecological and reproductive health. She is a Professor at the Department of Traditional Chinese Medicine, Shandong Provincial Hospital Affiliated to Shandong First Medical University, China. With a Ph.D. in Gynecology of TCM from Guangzhou University of Chinese Medicine, her research focuses on TCM treatments for infertility, gynecological tumors, pregnancy disorders, breast diseases, and reproductive endocrine diseases. Prof. Cai has published extensively in peer-reviewed journals and actively contributes to advancing TCM-based therapies. Her expertise integrates classical TCM principles with modern biomedical approaches, making significant contributions to women’s health. She has received numerous accolades for her research and clinical excellence. 🌿🏥📚

Publication Top Notes

scopus

🎓 Education

Prof. Pingping Cai earned her Ph.D. in Gynecology of TCM from Guangzhou University of Chinese Medicine (2003-2006), where she focused on integrating classical Chinese medical theories with modern gynecological treatments. She completed her Master’s degree in Gynecology of TCM at Shandong University of Traditional Chinese Medicine (2000-2003), deepening her expertise in diagnosing and treating gynecological disorders using herbal medicine and acupuncture. Her Bachelor’s degree in Chinese Medicine from the same university (1992-1997) laid a strong foundation in TCM principles, pulse diagnosis, and herbal formulations. Throughout her academic journey, she gained extensive knowledge in reproductive endocrinology, pregnancy-related disorders, and the holistic management of female health conditions. Her education was enriched by hands-on clinical training and research in renowned hospitals, allowing her to develop innovative TCM-based approaches for treating complex gynecological diseases. Her academic excellence and research contributions have significantly shaped the integration of TCM into modern medical practice. 🎓📖🌱

💼 Experience

Since 2006, Prof. Pingping Cai has been serving as a Professor in the Department of Traditional Chinese Medicine at Shandong Provincial Hospital Affiliated to Shandong First Medical University, where she specializes in treating infertility, gynecological tumors, and pregnancy-related conditions using TCM. She plays a crucial role in integrating TCM with modern gynecology, mentoring young researchers, and advancing clinical methodologies. Before her current role, she worked at Qingdao Licang District Hospital (1997-2000) in the Department of Chinese Medicine, focusing on herbal formulations and acupuncture therapies for women’s health issues. Her clinical expertise includes managing polycystic ovary syndrome (PCOS), endometriosis, and menopause symptoms through personalized herbal prescriptions. She has contributed to numerous hospital-based research projects and collaborated with multidisciplinary teams to enhance the efficacy of TCM treatments. Her commitment to innovation and evidence-based practice has made her a leading figure in TCM gynecology. 🏥🌿👩‍⚕️

🏅 Awards & Honors

Prof. Pingping Cai has received numerous awards for her contributions to Traditional Chinese Medicine and women’s health. She has been honored with the Outstanding Researcher Award in TCM Gynecology for her groundbreaking studies on herbal treatments for infertility. She was recognized by the Chinese Society of Traditional Medicine for her advancements in integrating TCM with reproductive endocrinology. Her work on the role of TCM in treating ovarian disorders earned her the Best Clinical Innovation Award. She also received the Excellence in Academic Publishing Award for her high-impact research papers in leading medical journals. Additionally, her contributions to education and mentorship have been acknowledged with the Distinguished Educator Award. She has been invited as a keynote speaker at international TCM conferences and serves as an editorial board member for several prestigious journals. Her dedication to advancing TCM in gynecological health continues to inspire the next generation of practitioners. 🏆📜🌏

🔬 Research Focus

Prof. Pingping Cai specializes in the Traditional Chinese Medicine treatment of gynecological and reproductive disorders. Her research focuses on TCM-based therapies for infertility, exploring the effects of herbal medicine and acupuncture on reproductive health. She investigates the role of TCM in treating gynecological tumors, examining herbal formulations that regulate tumor growth and immune responses. She is also dedicated to studying TCM interventions for pregnancy complications, including miscarriage prevention and fetal development. Her work on breast diseases highlights the effectiveness of TCM in managing mastitis and hormonal imbalances. Another key area of her research is the treatment of reproductive endocrine diseases, where she explores the impact of TCM on hormonal regulation in conditions like polycystic ovary syndrome (PCOS) and premature ovarian failure. Through clinical trials and molecular research, she aims to bridge traditional practices with modern medical advancements. Her contributions significantly enhance the understanding and application of TCM in gynecology. 🌿🩺📊

 

Publication Top Notes

  • Xu Y, Li Y, Zhang J, Cai P. “Hua Yu Xiao Zheng decoction induces ectopic endometrial stromal cell senescence via inhibiting the PI3K/AKT signaling.” Tissue Cell. 2025 Apr;93:102763.

  • Shao W, Lin Z, Xiahou Z, Zhao F, Xu J, Liu X, Cai P. “Single-cell RNA sequencing reveals that MYBL2 in malignant epithelial cells is involved in the development and progression of ovarian cancer.” Front Immunol. 2024 Jul 29;15:1438198.

  • Wang Y, Cai P, Qi F. “Examination and analysis of the disease evidence of ‘retention of placenta’.” China Journal of Basic Medicine in Traditional Chinese Medicine. 2024;30(10):1633-1637.

  • Wang Z, Cai P. “Cai Pingping’s experience in treating subchorionic hematoma based on the Eight Principles of Syndrome Differentiation.” Shanghai Journal of Traditional Chinese Medicine. 2024;58(04):54-57.

  • Yan R, He J, Xue Y, Wang Y, Dong R, Cai P. “Study on the dosage pattern of Chinese herbal enema formula for the treatment of sequelae of pelvic inflammatory diseases.” Chinese Traditional Patent Medicine. 2024;46(10):3492-3496.

  • Su N, Cai P, Dou Z, Yin X, Xu H, He J, Li Z, Li C. “Brain nuclei and neural circuits in neuropathic pain and brain modulation mechanisms of acupuncture: a review on animal-based experimental research.” Front Neurosci. 2023 Aug 30;17:1243231.

  • Wang Y, Qiu H, Yan R, Jing W, Li J, Cai P. “Mechanisms associated with the treatment of premature ovarian insufficiency by Zuogui Pill’s formula based on differential analysis of microRNAs and network pharmacology.” Chinese Archives of Traditional Chinese Medicine. 2023;41(04):81-86+269-273.

  • Wang Y, Yan R, Jing W, Cai P. “Investigating the mechanisms of Bei Sha Shen-Yu Zhu in the treatment of premature ovarian failure based on network pharmacology and molecular docking technique.” Traditional Chinese Drug Research and Clinical Pharmacology. 2022;33(05):645-654.

  • Wang Z, Qi F, Cui Y, Zhao L, Sun X, Tang W, Cai P. “An update on Chinese herbal medicines as adjuvant treatment of anticancer therapeutics.” Biosci Trends. 2018;12(3):220-239.

  • Cai P, Liu X, Xu Y, Qi F, Si G. “Shenqi detoxification granule combined with P311 inhibits epithelial-mesenchymal transition in renal fibrosis via TGF-β1-Smad-ILK pathway.” Biosci Trends. 2017;11(6):640-650.

 

 

 

Dr. Miguel Virseda-Chamorro | Medicine | Best Paper Award

Dr. Miguel Virseda-Chamorro | Medicine | Best Paper Award 

Dr. Miguel Virseda-Chamorro, FEA, Hospital Nacional de parapléjicos, Spain.

Miguel Vírseda Chamorro is a seasoned medical professional with expertise in urology. Born in Zaragoza, Spain, in 1956, Miguel has dedicated over three decades to research, education, and clinical practice in the field of urology. Throughout his career, he has specialized in the treatment of lower urinary tract disorders, urological dysfunctions, and has made significant contributions through his research in the field of neurourology and urodynamics.

Profile

scopus

orcid

Strengths for the Award

  1. Extensive Research Background: Chamorro has participated in numerous clinical trials and published papers over decades, specifically focusing on urology and related areas such as spinal cord injuries and urinary tract infections.
  2. Recognized Expertise: His work has been acknowledged with multiple awards and recognitions, including best doctoral thesis and research prizes in the field of urology.
  3. International Contributions: Chamorro’s involvement in various international scientific meetings (e.g., International Continence Society) and peer-reviewed publications highlights his contributions to global scientific dialogue.
  4. Educational Contributions: Directing doctoral theses and contributing to advanced academic courses in urology positions him as a thought leader in his field.

Areas for Improvement

  • Interdisciplinary Reach: While his work is specialized in urology, expanding to interdisciplinary research that bridges other medical fields or innovations in treatment techniques might add depth to his paper’s impact.

Novel Research: Chamorro has done extensive work on known conditions, but for a “Best Paper Award,” research on cutting-edge topics, such as emerging technologies or new medical approaches, could further elevate his candidacy.

Education 🎓

Miguel Vírseda Chamorro has a diverse and accomplished educational background. He began his academic journey with a degree in Industrial Engineering at the Universidad Politécnica de Las Palmas in 1973. He later obtained his Licenciatura in Medicine and Surgery from the University of Valencia in 1981, followed by a degree in Law from the National University of Distance Education (UNED) in 2011. He specialized in Urology at Hospital Gómez Ulla in 1990 and pursued further studies, earning a Master’s in Design and Statistics in Health Sciences from the Autonomous University of Barcelona in 2001. His Doctoral Thesis, completed in 1992, received the prestigious Cum Laude distinction.

Experience 💼

Miguel’s career spans over three decades, including extensive experience in urological surgery, teaching, and research. He became a Fellow of the European Board of Urology in 1992 and has been an accredited Professor since 2005, working with several medical institutions. His medical experience is also enriched by his work as Director of Radiodiagnostic Installations, certified by the Spanish Nuclear Safety Council in 2007. He has served in various clinical roles, significantly contributing to both the practice and teaching of urology and urodynamics.

Research Interests 🔬

Miguel’s primary research interests lie in neurourology, urodynamics, and the impact of pelvic dysfunction on urinary systems. His research has focused on urinary tract dysfunctions, neurogenic detrusor overactivity, and the application of botulinum toxin in urological conditions. He is particularly interested in exploring diagnostic techniques, treatment methods, and prognostic factors for patients with spinal cord injuries and other neurological disorders affecting urological health.

Awards and Recognition 🏆

Miguel has been recognized with numerous awards for his outstanding work in the field of urology. In 1992, his doctoral thesis was awarded the Best Thesis Prize by the Spanish Association of Urology. He has received multiple accolades, including the Enrique Pérez Castro Third Prize for his research on urodynamic models in 1998, and the distinction for “Best Urological Functional Case” at the National Urology Congress in 2011. His latest recognition includes the ACACI Research Award for his study on chronic pelvic pain syndrome in women.

Publications 📚

Miguel has published extensively in renowned medical journals, contributing significantly to the field of urology. Below are some of his recent publications:

    1. Abdominal strength in voiding cystometry: a risk factor for recurrent urinary tract infections in women. Int Urogynecol J, 2015. Cited by: 45
    2. Risk factors of urethral diverticula in male patients with spinal cord injury. Spinal Cord, 2015. Cited by: 23
    3. Post Pelvic Radiotherapy Affectation of the Lower Urinary Tract Peripheral Innervation in Men. Urol Int, 2017. Cited by: 18
    4. Influence of bladder lithiasis on lower urinary tract dynamics in patients with spinal cord injury. Spinal Cord, 2017. Cited by: 30
    5. Clinical and urodynamic risk factors for recurrent urinary tract infections in multiple sclerosis. Multiple Sclerosis Journal, 2018. Cited by: 35

Conclusion

Chamorro’s achievements in urology and academic research, coupled with his global recognition, make him a strong contender for the award. Expanding his research focus and emphasizing innovation in his recent work would further bolster his potential for winning.

Jianglan Long | Medicine and Dentistry | Best Innovation Award

Jianglan Long | Medicine and Dentistry | Best Innovation Award

Dr Jianglan Long,Beijing Institute of Clinical Pharmacy, Beijing Friendship Hospital, Capital Medical University,China

Dr. Jianglan Long is a dedicated Researcher Intern at Beijing Institute of Clinical Pharmacy, affiliated with Beijing Friendship Hospital and Capital Medical University. Specializing in intelligent molecular diagnostics and drug intervention mechanisms for pre-diabetes and type 2 diabetes, Dr. Long has published several impactful papers. Notable works include studies in International Journal of Biological Macromolecules (2024) on innovative diabetes treatments, and contributions to Diabetes Obesity & Metabolism (2024) on predictive biomarker profiling. Dr. Long is a pioneer in developing integrated diagnostic tools and advancing diabetes treatment in China. 🌟🔬📚

Publication profile

Scopus

Academic and Professional Background

Dr. Jianglan Long is a prominent researcher based at the Beijing Institute of Clinical Pharmacy, affiliated with Beijing Friendship Hospital, Capital Medical University. His primary focus lies in the exploration of intelligent molecular diagnosis and drug intervention mechanisms for prediabetes and type 2 diabetes. Dr. Jianglan Long has made significant contributions to this field, evidenced by his publications in reputable journals such as the International Journal of Biological Macromolecules (2024), Diabetes Obesity & Metabolism (2024), Clinical and Translational Medicine (2021), BMC Endocrine Disorders (2020), and Rapid Communications in Mass Spectrometry (2020), where he served as the first author.

 

Research focus

Category: Research Focus on Intelligent Molecular Diagnosis and Drug Intervention for Diabetes

Jianglan Long’s research centers on advancing the field of intelligent molecular diagnostics and drug interventions for pre-diabetes and type 2 diabetes. Her work includes pioneering biomarker profiling for early disease detection and the enhancement of metformin therapy with innovative treatments, like low molecular weight polysaccharides from Astragalus membranaceus. With twelve published journals and ongoing research, her contributions are crucial for improving diabetes management and treatment outcomes in China and potentially worldwide. 📊🔬💊🌍

Publication top notes

Structural characterization of Astragalus polysaccharide-D1 and its improvement of low-dose metformin effect by enriching Staphylococcus lentus

Uncovering the key pharmacodynamic material basis and possible molecular mechanism of Xiaoke formulation improve insulin resistant through a comprehensive investigation

Rapid multichannel fluorescent probe assay for CYP450 inhibition screening and drug interaction monitoring

Novel weight loss diet attenuates dietary-induced obesity in mice and might correlate with altered gut microbiota and metabolite profiles

Polystyrene microplastic exposure induces insulin resistance in mice via dysbacteriosis and pro-inflammation

Evaluation of interaction of chlorogenic acid and cefotaxime sodium based on sequential analysis

Network pharmacology-based dissection of the underlying mechanisms of dyspnoea induced by zedoary turmeric oil

Metabolomics based plasma biomarkers for diagnosis of oral squamous cell carcinoma and oral erosive lichen planus